12:00 AM
 | 
Aug 01, 2016
 |  BC Week In Review  |  Company News  |  Deals

Acino, Luye deal

Luye will acquire Acino’s transdermal drug delivery business for EUR245 million ($268.6 million). Acino said the deal is expected to close this half. The sale includes Acino’s transdermal...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >